Publications by authors named "R Descourt"

Claim this Profile
R
Real-world efficacy and safety of amivantamab in EGFR exon-20-mutant non-small cell lung cancer in a French early-access program: Amexon 20 GFPC study.
Thomas Pierret, Laurent Greillier, Florian Guisier, Catherine Daniel, Renaud Descourt

Lung Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival impact of a KEAP1-NFE2L2 radiomics model in PDL1 ≥ 50% non-small cell lung cancer treated with pembrolizumab: the PEMBROMIC study.
Coline Le Meur, Karim Amrane, Renaud Descourt, Matthieu Chasseray, Olivier Pradier

Cancer Imaging· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life Experience of Rare Hepatoid Adenocarcinomas of the Lung: A Large Retrospective French Cohort.
Thomas Fave, Jessica Nguyen, Renaud Descourt, Gilles Quéré, Estelle Dhamelincourt

Clin Lung Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alectinib Efficacy Post-Brigatinib Against Advanced + Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study).
Renaud Descourt, Florian Guisier, Maurice Pérol, Jacques Cadranel, Helene Doubre

Lung Cancer (Auckl)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysis.
K Amrane, B Cabarrou, G Justeau, S Schneider, X Quantin, R Descourt

ESMO Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis